Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas

Abstract

Prognostication and related clinical decision making in the majority of patients with melanoma can be improved now using the validated, SEER-based classification. Tumor cell mitotic rate should be incorporated into the next iteration of AJCC staging.